We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
-$9.81M
Cap. Flow
-$12.1M
Cap. Flow %
-10.37%
Top 10 Hldgs %
48.94%
Holding
61
New
9
Increased
18
Reduced
15
Closed
17

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$4.9M
2
AWI icon
Armstrong World Industries
AWI
+$1.98M
3
KKR icon
KKR & Co
KKR
+$1.89M
4
KALA icon
KALA BIO
KALA
+$1.87M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$1.87M

Top Sells

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$3.74M
2
RXDX
Ignyta, Inc.
RXDX
+$2.11M
3
WBC
WABCO HOLDINGS INC.
WBC
+$1.74M
4
ESPR
Esperion Therapeutics
ESPR
+$1.7M
5
QVCGA
QVC Group Inc Series A
QVCGA
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 44.68%
2 Financials 35.04%
3 Consumer Discretionary 4.42%
4 Industrials 3.63%
5 Technology 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKR icon
26
Baker Hughes
BKR
$55.5B
$1.87M 1.6%
58,965
+10,938
+23% +$351K
AAAP
27
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$1.84M 1.58%
+22,538
New +$1.75M
CBRE icon
28
CBRE Group
CBRE
$41.3B
$1.83M 1.57%
42,266
-3,376
-7% -$140K
KALA icon
29
KALA BIO
KALA
$14.4M
$1.83M 1.57%
+40
New +$1.87M
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$35.7B
$1.82M 1.56%
14,344
-6,316
-31% -$794K
SMC
31
Summit Midstream
SMC
$407M
$1.79M 1.54%
5,837
– –
TVTX icon
32
Travere Therapeutics
TVTX
$5.27B
$1.79M 1.54%
84,885
+10,968
+15% +$251K
GBT
33
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.79M 1.53%
45,441
-10,716
-19% -$400K
SGEN
34
DELISTED
Seagen Inc. Common Stock
SGEN
$1.7M 1.45%
31,683
-4,299
-12% -$251K
TSRO
35
DELISTED
TESARO, Inc.
TSRO
$1.69M 1.45%
20,407
+5,878
+40% +$576K
PBYI icon
36
Puma Biotechnology
PBYI
$434M
$1.69M 1.45%
17,044
-3,511
-17% -$393K
AVEO
37
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.68M 1.44%
+60,288
New +$1.87M
LJPC
38
DELISTED
La Jolla Pharmaceutical Company
LJPC
$1.66M 1.43%
51,632
-1,122
-2% -$36.7K
MYOV
39
DELISTED
Myovant Sciences Ltd.
MYOV
$1.66M 1.42%
131,363
-25,940
-16% -$348K
CORI
40
DELISTED
Corium International, Inc.
CORI
$1.61M 1.39%
+168,053
New +$1.79M
INCY icon
41
Incyte
INCY
$23.4B
$1.61M 1.38%
17,046
+4,016
+31% +$420K
ACHN
42
DELISTED
Achillion Pharmaceuticals
ACHN
$1.49M 1.28%
518,223
+180,360
+53% +$655K
SPY icon
43
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$237K 0.2%
+889
New +$231K
AAPL icon
44
Apple
AAPL
$4.9T
$230K 0.2%
+5,436
New +$227K
ACGL icon
45
Arch Capital
ACGL
$35.4B
– –
-51,066
Closed -$1.68M
VISN
46
Vistance Networks Inc
VISN
$2.74B
– –
-50,472
Closed -$1.68M
ESPR
47
DELISTED
Esperion Therapeutics
ESPR
– –
-33,975
Closed -$1.7M
KMI icon
48
Kinder Morgan
KMI
$71.9B
– –
-86,463
Closed -$1.66M
VSAT icon
49
Viasat
VSAT
$9.76B
– –
-26,368
Closed -$1.7M
WTW icon
50
Willis Towers Watson
WTW
$27.7B
– –
-10,874
Closed -$1.68M
1
2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q4 2017 Portfolio in Review

As of Q4 2017, Emory University held 61 positions worth $117M, down 7.8% from $126M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Emory University withdrew a net $12.1M in Q4 2017, closing 17 positions and reducing 15 holdings. Its most notable exit was Ignyta, Inc., an estimated $2.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Emory University opened a new position in JD.com worth $5.15M.

  • Emory University's largest Q4 2017 buy was JD.com: 124,440 shares worth $5.15M.
  • Emory University added most to DBV Technologies in Q4 2017, an estimated $1.26M increase.
  • Emory University's biggest Q4 2017 reduction was Zogenix, Inc., cutting an estimated $3.74M.
  • Emory University fully exited Ignyta, Inc. in Q4 2017, selling an estimated $2.11M.
  • Emory University's ten largest holdings make up 49% of its $117M portfolio in Q4 2017.
  • Emory University opened 9 new positions and closed 17 in Q4 2017.
  • Emory University's portfolio value fell 7.8% quarter-over-quarter to $117M.

Based on Emory University's 13F filing for Q4 2017, filed 13 Feb 2018.